4//SEC Filing
Newman Mark 4
Accession 0001627223-22-000037
CIK 0001627223other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 7:52 PM ET
Size
9.7 KB
Accession
0001627223-22-000037
Insider Transaction Report
Form 4
Newman Mark
SVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2022-05-05$16.04/sh+197,161$3,162,462→ 373,508.035 total - Sale
Common Stock
2022-05-05$40.22/sh−197,161$7,929,815→ 176,347.035 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-05−197,161→ 0 totalExercise: $16.04From: 2018-03-01Exp: 2025-07-05→ Common Stock (197,161 underlying)
Holdings
- 2,480(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]Includes directly owned shares, restricted stock units and dividend equivalent units.
- [F2]Shares were sold in multiple transactions at prices ranging from $40.00 to $40.50.
- [F3]Stock options granted in accordance with the Employee Matters Agreement dated as of June 26, 2015 between the Issuer and E. I. du Pont de Nemours and Company ("DuPont") to replace 2015 performance share awards of DuPont held by the Reporting Person immediately before the legal and structural separation of Issuer from DuPont. The vesting date of the stock options is the date the 2015 DuPont performance share awards would have vested.
Documents
Issuer
Chemours Co
CIK 0001627223
Entity typeother
Related Parties
1- filerCIK 0001524597
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 7:52 PM ET
- Size
- 9.7 KB